1 minute reading time (93 words)

Statin users have an elevated risk of dysglycemia and new-onset-diabetes.

Taking statin pills may increase the glycated hemoglobin (HbA1c) number and diabetes risk of an individual.

​This research work studied the impact of statin therapy on the blood levels of glycated hemoglobin (HbA1c)—an indicator of glycemic control— and diabetes risk. Researchers analyzed the drug and health records of 7,064 US men and women. 

The research team found a significant increase in plasma concentrations of glycated hemoglobin and diabetes risk among individuals on statin medications. The results of this study demonstrated that statin drugs may impair glycemic control and accelerate the development of diabetes.

Research Summary Information

  • 2019
  • Zigmont VA, Shoben AB, Lu B, Kaye GL, Clinton SK, Harris RE, Olivo-Marston SE.
  • College of Public Health, Division of Epidemiology, The Ohio State University, Columbus, OH, USA. College of Public Health, Division of Biostatistics, The Ohio State University, Columbus, OH, USA. College of Public Health, Division of Health Promotion, The Ohio State University, Columbus, OH, USA. College of Medicine, Department of Internal Medicine, Division of Medical Oncology, The Ohio State University, Columbus, OH, USA.
  • Yes, Free full text of study was found:
Statin Use and Gastrointestinal Hemorrhage: A Larg...
Statin use increased new-onset diabetes in hyperch...

Related Posts

 

Comments (0)

Rated 0 out of 5 based on 0 voters
There are no comments posted here yet

Leave your comments

  1. Posting comment as a guest. Sign up or login to your account.
Rate this post:
Attachments (0 / 3)
Share Your Location

By accepting you will be accessing a service provided by a third-party external to https://www.drcarney.com/